← All organizations
Eastern Hepatobiliary Surgery Hospital
Academic/HospitalWebsite ↗
Also known as: Eastern Hepatobiliary Surgery Hospital | Eastern Hepatobiliary Surgery Hospital, Shanghai, China | Eastern Hepatobiliary Surgical Hospital | Eastern hepatobilliary surgery hospital | ShenFeng | Shuqun Cheng | Zhengang Yuan
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2008Last known activity
Nov 30, 2025
Timeline
1950s
- Jan 1, 1956
Eastern Hepatobiliary Surgery Hospital— Founded
Drugs by trial phase (76 distinct, 63 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (37 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Bile Duct Neoplasms
- Biliary Tract Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Delayed Emergence from Anesthesia
- Esophageal and Gastric Varices
- Fibrosis
- Gallbladder Neoplasms
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Liver Cirrhosis
- Liver Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Pancreatitis
- Postoperative Complications
- Recurrence
- Stomach Neoplasms
- Thrombosis
- Venous Thrombosis
Recent trials (50)
- NCT07129018OfficialPhase 2Nov 30, 2025
- NCT07285850Lead sponsorPhase 2/Phase 3Oct 20, 2025
- NCT07285850Sponsor investigatorPhase 2/Phase 3Oct 20, 2025
- NCT06902389Sponsor investigatorPhase 1/Phase 2Jul 30, 2025
- NCT06902389Lead sponsorPhase 1/Phase 2Jul 30, 2025
- NCT07186621CollaboratorPhase 3Jul 10, 2025
- NCT06892925OfficialPhase 2Jun 14, 2025
- NCT06892925Sponsor investigatorPhase 2Jun 14, 2025
- NCT06892925Lead sponsorPhase 2Jun 14, 2025
- NCT06818773Lead sponsorPhase 4Feb 28, 2025
- NCT06818773Sponsor investigatorPhase 4Feb 28, 2025
- NCT06530823Sponsor investigatorPhase 2Aug 1, 2024
- NCT06530823Lead sponsorPhase 2Aug 1, 2024
- NCT06361758CollaboratorPhase 2May 31, 2024
- NCT06210334Sponsor investigatorPhase 2Mar 31, 2024
Details
- Founded
- Shanghai, CN Jan 1, 1956
- Last known activity
- Nov 30, 2025